Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide for Antepartum Severe Hypertension
NCT04615624Phase 3Completed
- Start
- Jan 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in preeclampsia and hypertension (HTN) comparing Furosemide Arm with Placebo Arm (2 arms). Primary endpoint: Mean Systolic Blood Pressure During Hour After Study Drug. Started Jan 2021; status: completed.
02
Drugs
furosemide
03
Conditions
preeclampsiahypertension (HTN)
Beyond the preview
Go deeper on NCT04615624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04615624.